3 Articles
3 Articles
All
Left
Center
1
Right
TYK2 Inhibitors Show Impressive Efficacy for Psoriasis
ORLANDO, Fla. — In moderate to severe plaque psoriasis, two highly selective oral TYK2 inhibitors produced a level of response in phase 2 studies suggesting that drugs in this class might rival biologics. In one, a 75% skin clearance on the Psoriasis Area Severity Index (PASI) was achieved with a drug currently known as ICP-488 […] The post TYK2 Inhibitors Show Impressive Efficacy for Psoriasis first appeared on News Health.
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage